药物警戒
医学
立场声明
数据库
医疗保健
职位(财务)
立场文件
数据科学
家庭医学
药理学
病理
药品
财务
计算机科学
经济增长
经济
作者
Salvatore Crisafulli,Andrew Bate,Jackie Brown,Gianmario Candore,Rebecca E. Chandler,Tarek A. Hammad,Samantha Lane,Judith C. Maro,G. Niklas Norén,Alexandre Pariente,Mulugeta Russom,Maribel Salas,Andrej Segec,Saad Shakir,Andrea Spini,Sengwee Toh,Marco Tuccori,Eugène van Puijenbroek,Gianluca Trifirò
出处
期刊:Drug Safety
[Adis, Springer Healthcare]
日期:2025-04-13
被引量:1
标识
DOI:10.1007/s40264-025-01548-3
摘要
Signal management, defined as the set of activities from signal detection to recommendations for action, is conducted using different data sources and leveraging data from spontaneous reporting databases (SRDs), which represent the cornerstone of pharmacovigilance. However, the exponentially increasing generation and availability of real-world data collected in longitudinal healthcare databases (LHDs), along with the rapid evolution of artificial intelligence-based algorithms and other advanced analytical methods, offers a wide range of opportunities to complement SRDs throughout all stages of signal management, especially signal detection. Integrating information derived from SRDs and LHDs may reduce their respective limitations, thus potentially enhancing post-marketing surveillance. The aim of this position statement is to critically evaluate the complementary role of SRDs and LHDs in signal management, exploring the potential benefits and challenges in integrating information coming from these two data sources. Furthermore, we presented successful cases of the interplay between SRDs and LHDs for signal management, along with future opportunities and directions to improve such interplay.
科研通智能强力驱动
Strongly Powered by AbleSci AI